📰 Top Line Data News
Top Line Data News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Top Line Data. Real-time updates on events, politics, business and more.
October 17, 2022
Presentation at the 18th meeting of the International Society of NeuroVirology showing for the first time top-line results of collaborative efforts ran in the context of COVID-19 with institutions
May 12, 2022
The great news is that NWBO’s quiet period is over so it can now fight back with some important announcements of combo trials with other drugs.
May 10, 2022
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...
February 11, 2022
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the fourth quarter and fiscal year ended December 31,...
February 11, 2022
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the fourth quarter and fiscal year ended December 31,...
October 20, 2021
The biden white house pointed out today theyll be able to deliver 15 million of these doses to pharmacies and clinics one week after authorization, as you mentioned. so were looking at probably like the week of november 10, kind of around that time, because the cdc is meeting on the 2nd. but youre right, the childrens infrastructure for pediatric immunizations is something we should try to mimic and copy. i do feel like it will take weeks for this to really kind of settle in across the country. ...
October 15, 2021
Data. the top line data that we have is from the press releases from pfizer. looks like its great in terms of its effectiveness, in terms of the response. i also want to see the data. once the fda committee meets and the cdc meets and they provide the recommendation, im looking forward to getting my children vaccinated. we want to go back to normalish as soon as possible for our children as well. >> neil: i like that normaish. we dont know what that is anymore. but one thing about the booster pu...
September 20, 2021
Good news. does it beg more investigation? >> what the companies typically do is put out high level top line data. that generates enthusiasm and holds at bay the critics who will look deep into the data like myself. there are concerns about the second dose in healthy children specifically boys. a study out of davis just 3 weeks ago found 1 in 6,000 boys 12 through 16 who get the second dose get serious heart symptoms. thats 6 times higher than the rate of hospitalizations for the infection itsel...